| Product Code: ETC7647226 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Candidiasis Therapeutics Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Candidiasis Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Candidiasis Therapeutics Market - Industry Life Cycle |
3.4 Israel Candidiasis Therapeutics Market - Porter's Five Forces |
3.5 Israel Candidiasis Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Candidiasis Therapeutics Market Revenues & Volume Share, By Symptom Type, 2021 & 2031F |
3.7 Israel Candidiasis Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 Israel Candidiasis Therapeutics Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.9 Israel Candidiasis Therapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 Israel Candidiasis Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Candidiasis Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of candidiasis infections in Israel |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of candidiasis |
4.2.3 Advancements in healthcare infrastructure and technologies in Israel |
4.3 Market Restraints |
4.3.1 High cost associated with candidiasis therapeutics |
4.3.2 Limited availability of specialized healthcare facilities for candidiasis treatment in certain regions of Israel |
4.3.3 Potential side effects and resistance development to current candidiasis treatments |
5 Israel Candidiasis Therapeutics Market Trends |
6 Israel Candidiasis Therapeutics Market, By Types |
6.1 Israel Candidiasis Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Candidiasis Therapeutics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Candidiasis Therapeutics Market Revenues & Volume, By Oropharyngeal Candidiasis, 2021- 2031F |
6.1.4 Israel Candidiasis Therapeutics Market Revenues & Volume, By Genital Candidiasis, 2021- 2031F |
6.1.5 Israel Candidiasis Therapeutics Market Revenues & Volume, By Invasive Candidasis, 2021- 2031F |
6.2 Israel Candidiasis Therapeutics Market, By Symptom Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Candidiasis Therapeutics Market Revenues & Volume, By Oral Thrush, 2021- 2031F |
6.2.3 Israel Candidiasis Therapeutics Market Revenues & Volume, By Fatigue, 2021- 2031F |
6.2.4 Israel Candidiasis Therapeutics Market Revenues & Volume, By Urinary Tract Infection (UTI), 2021- 2031F |
6.3 Israel Candidiasis Therapeutics Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 Israel Candidiasis Therapeutics Market Revenues & Volume, By Medication, 2021- 2031F |
6.3.3 Israel Candidiasis Therapeutics Market Revenues & Volume, By Surgery, 2021- 2031F |
6.4 Israel Candidiasis Therapeutics Market, By Mode of Administration |
6.4.1 Overview and Analysis |
6.4.2 Israel Candidiasis Therapeutics Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.3 Israel Candidiasis Therapeutics Market Revenues & Volume, By Oral, 2021- 2031F |
6.5 Israel Candidiasis Therapeutics Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Candidiasis Therapeutics Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 Israel Candidiasis Therapeutics Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 Israel Candidiasis Therapeutics Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6 Israel Candidiasis Therapeutics Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 Israel Candidiasis Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Israel Candidiasis Therapeutics Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 Israel Candidiasis Therapeutics Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 Israel Candidiasis Therapeutics Market Import-Export Trade Statistics |
7.1 Israel Candidiasis Therapeutics Market Export to Major Countries |
7.2 Israel Candidiasis Therapeutics Market Imports from Major Countries |
8 Israel Candidiasis Therapeutics Market Key Performance Indicators |
8.1 Number of new diagnosed candidiasis cases in Israel |
8.2 Percentage of healthcare professionals educated about candidiasis management |
8.3 Research and development investment in innovative candidiasis therapeutics |
9 Israel Candidiasis Therapeutics Market - Opportunity Assessment |
9.1 Israel Candidiasis Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Candidiasis Therapeutics Market Opportunity Assessment, By Symptom Type, 2021 & 2031F |
9.3 Israel Candidiasis Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 Israel Candidiasis Therapeutics Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.5 Israel Candidiasis Therapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 Israel Candidiasis Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Candidiasis Therapeutics Market - Competitive Landscape |
10.1 Israel Candidiasis Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Israel Candidiasis Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here